Update on terbinafine with a focus on dermatophytoses

References

• BrownMTraynorMTreatment of fungal nail infectionsDrug Delivery Report2007Spring–Summer1719
   Google Scholar
• SuhDCShinHRautMTavakkolAUsage patterns of medical services and prescription drugs in patients with tinea capitisJ Am Acad Dermatol20045086
   Web of Science ®Google Scholar
• BirnbaumJEPharmacology of the allylaminesJ Am Acad Dermatol1990234 Pt 27827852229523
   PubMed Web of Science ®Google Scholar
• GanzingerUStutzAPetranyiGStephenAAllylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agentsActa Derm Venereol Suppl (Stockh)19861211551603459341
   PubMedGoogle Scholar
• RyderNSSpecific inhibition of fungal sterol biosynthesis by SF 86–327, a new allylamine antimycotic agentAntimicrob Agents Chemother19852722522564039119
   PubMed Web of Science ®Google Scholar
• RyderNSTerbinafine: mode of action and properties of the squalene epoxidase inhibitionBr J Dermatol1992126 Suppl 39271543672
   PubMed Web of Science ®Google Scholar
• RyderNSDupontMCInhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymesBiochem J198523037657703877503
   PubMed Web of Science ®Google Scholar
• ClaytonYMRelevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycosesBr J Dermatol1994130 Suppl 43788186143
   PubMed Web of Science ®Google Scholar
• DixonDMPolakAIn vitro and in vivo drug studies with three agents of central nervous system phaeohyphomycosisChemotherapy19873321291403568799
   PubMed Web of Science ®Google Scholar
• OddsFCEffects of temperature on anti-Candida activities of antifungal antibioticsAntimicrob Agents Chemother19933746856918494363
   PubMed Web of Science ®Google Scholar
• PetranyiGMeingassnerJGMiethHActivity of terbinafine in experimental fungal infections of laboratory animalsAntimicrob Agents Chemother19873110155815613435103
   PubMed Web of Science ®Google Scholar
• PetranyiGMeingassnerJGMiethHAntifungal activity of the allylamine derivative terbinafine in vitroAntimicrob Agents Chemother1987319136513683674847
   PubMed Web of Science ®Google Scholar
• PetranyiGRyderNSStutzAAllylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidaseScience19842244654123912416547247
   PubMed Web of Science ®Google Scholar
• SchmittHJBernardEMAndradeJEdwardsFSchmittBArmstrongDMIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus sppAntimicrob Agents Chemother19883257807813134851
   PubMed Web of Science ®Google Scholar
• ShadomySEspinel-IngroffAGebhartRJIn-vitro studies with SF 86–327, a new orally active allylamine derivativeSabouraudia19852321251322990057
   PubMedGoogle Scholar
• VenugopalPVVenugopalTVAntidermatophytic activity of allyl-amine derivativesIndian J Pathol Microbiol19943743813887868170
   PubMedGoogle Scholar
• Standards NCfCLReference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved StandardNCCLS document M38-A2Wayne, PAClinical and Laboratory Standards Institute2008
   Google Scholar
• GohCLTayYKAliKBKohMTSeowCSIn vitro evaluation of griseofulvin, ketoconazole, and itraconazole against various dermatophytes in SingaporeInt J Dermatol199433107337378002147
   PubMed Web of Science ®Google Scholar
• GrantSMClissoldSPItraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycosesDrugs19893733103442540949
   PubMed Web of Science ®Google Scholar
• HeelRCBrogdenRNCarmineAMorleyPASpeightTMAveryGSKetoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infectionsDrugs1982231–21366276122
   PubMed Web of Science ®Google Scholar
• HowardRAlyRFriedenIAnalysis of trychophyton tonsurans sensitivity to griseofulvin in vitro (abstract)Clin Res199341420A
   Google Scholar
• VenugopalPVVenugopalTVDisk diffusion susceptibility testing of dermatophytes with allylaminesInt J Dermatol199433107307328002146
   PubMed Web of Science ®Google Scholar
• VenugopalPVVenugopalTVAntidermatophytic activity of garlic (Allium sativum) in vitroInt J Dermatol19953442782797790146
   PubMed Web of Science ®Google Scholar
• da Silva BarrosMEde Assis SantosDHamdanJSEvaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A)J Med Microbiol200756Pt 451451817374893
   PubMed Web of Science ®Google Scholar
• GhannoumMAWraithLACaiBNyiradyJIshamNSusceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trialBr J Dermatol2008159371171318510668
   PubMed Web of Science ®Google Scholar
• CoelhoLMAquino-FerreiraRMaffeiCMMartinez-RossiNMIn vitro antifungal drug susceptibilities of dermatophytes microconidia and arthroconidiaJ Antimicrob Chemother200862475876118552341
   PubMed Web of Science ®Google Scholar
• ZengYBQianYSMaLGuHNGenome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysisChin Med J (Engl)2007120980781317531123
   PubMed Web of Science ®Google Scholar
• CervelattiEPFachinALFerreira-NozawaMSMartinez-RossiNMMolecular cloning and characterization of a novel ABC transporter gene in the human pathogen Trichophyton rubrumMed Mycol200644214114716519017
   PubMed Web of Science ®Google Scholar
• GraminhaMARochaEMPradeRAMartinez-RossiNMTerbinafine resistance mediated by salicylate 1-monooxygenase in Aspergillus nidulansAntimicrob Agents Chemother20044893530353515328121
   PubMed Web of Science ®Google Scholar
• OsborneCSHofbauerBFavreBRyderNSIn vitro analysis of the ability of Trichophyton rubrum to become resistant to terbinafineAntimicrob Agents Chemother200347113634363614576134
   PubMed Web of Science ®Google Scholar
• OsborneCSLeitnerIFavreBRyderNSAmino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafineAntimicrob Agents Chemother20054972840284415980358
   PubMed Web of Science ®Google Scholar
• OsborneCSLeitnerIHofbauerBFieldingCAFavreBRyderNSBiological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafineAntimicrob Agents Chemother20065062234223616723593
   PubMed Web of Science ®Google Scholar
• RochaEMAlmeidaCBMartinez-RossiNMIdentification of genes involved in terbinafine resistance in Aspergillus nidulansLett Appl Microbiol200235322823212180946
   PubMed Web of Science ®Google Scholar
• Martinez-RossiNMPeresNTRossiAAntifungal resistance mechanisms in dermatophytesMycopathologia20081665–636938318478356
   PubMed Web of Science ®Google Scholar
• Schuetzer-MuehlbauerMWillingerBKrapfGEnzingerSPresterlEKuchlerKThe Candida albicans Cdr2p ATP-binding cassette (ABC) transporter confers resistance to caspofunginMol Microbiol200348122523512657057
   PubMed Web of Science ®Google Scholar
• KohliASmritiMukhopadhyayKRattanAPrasadRIn vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetryAntimicrob Agents Chemother20024641046105211897588
   PubMed Web of Science ®Google Scholar
• MagaldiSMataSHartungCVerdeGDeibisLRoldanYIn vitro susceptibility of 137 Candida sp isolates from HIV positive patients to several antifungal drugsMycopathologia20011492636811265163
   PubMed Web of Science ®Google Scholar
• vanden BosscheHMarichalPOddsFCLe JeuneLCoeneMCCharacterization of an azole-resistant Candida glabrata isolateAntimicrob Agents Chemother19923612260226101482129
   PubMed Web of Science ®Google Scholar
• RyderNSLeitnerIActivity of terbinafine against Aspergillus in vitro, in combination with amphotericin B or triazoles (Abstract E54)36th Interscience Conference on Antimicrobial Agents and Chemotherapy1996 Sept 15–18New Orleans, LA1996
   Google Scholar
• FothergillAWLeitnerIMeingassnerJGRyderNSRinaldiMGCombination antifungal susceptibility testing of terbinafine and the triazoles fluconazole and itraconazole (Abstract E53)36th Interscience Conference on Antimicrobial Agents and Chemotherapy1996 September 15–18New Orleans, LA1996
   Google Scholar
• RoderoLVitaleRHochenfellnerFCanteosCDavelGIn vitro activity of terbinafine in combination with triazole drugs against fluconazole resistant candida species (Abstract E56)36th Interscience Conference on Antimicrobial Agents and Chemotherapy1996 September 15–18New Orleans, LA1996
   Google Scholar
• LiLWangZLiRLuoSSunXIn vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patientsAm J Ophthalmol2008146572472818707669
   PubMed Web of Science ®Google Scholar
• Abdel-RahmanSMHerronJFallon-FriedlanderSHauffeSHorowitzARiviereGJPharmacokinetics of terbinafine in young children treated for tinea capitisPediatr Infect Dis J2005241088689116220086
   PubMed Web of Science ®Google Scholar
• NejjamFZagulaMCabiacMDGuessousNHumbertHLakhdarHPilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokineticsBr J Dermatol19951321981057756158
   PubMed Web of Science ®Google Scholar
• JiangXWangNZhangZJTianYChenYPharmacokinetics and comparative bioavailability of two terbinafine hydrochloride formulations after single-dose administration in Chinese healthy subjectsArzneimittelforschung200858736336618751504
   PubMed Web of Science ®Google Scholar
• KovarikJMMuellerEAZehenderHDenouelJCaplainHMilleriouxLMultiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolitesAntimicrob Agents Chemother19953912273827418593011
   PubMed Web of Science ®Google Scholar
• FaergemannJZehenderHDenouelJMilleriouxLLevels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeksActa Derm Venereol19937343053097904107
   PubMed Web of Science ®Google Scholar
• CramerJKshatriyaBSnoddyASkin pharmacokinetics of terbinafine in healthy subjects following once-daily application of 1% emulsion gel or 1% cream for 1, 5, or 7 daysAmerican College of Clinical Pharmacy Annual Meeting2006 October 26St. Louis, MO2006
   Google Scholar
• DenouellJBurtinPKshatriyaBSnoddyAPharmacokinetics of terbinafine 1% emulsion gel in healthy volunteers and in patients with tinea cruris/corporisAmerican College of Clinical Pharmacy Annual Meeting2006St. Louis, MO20061026
   Google Scholar
• KienzlerJLQueille-RousselCMugglestoneCOrtonneJPLarnierCStratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytosesCurr Med Res Opin20072361293130217559730
   PubMed Web of Science ®Google Scholar
• GuptaAKSauderDNShearNHAntifungal agents: an overview. Part IIJ Am Acad Dermatol199430691133 quiz 34–67619094
   PubMed Web of Science ®Google Scholar
• JensenJCClinical pharmacokinetics of terbinafine (Lamisil)Clin Exp Dermatol19891421101132689012
   PubMed Web of Science ®Google Scholar
• KovarikJMKirkesseliSHumbertHGrassPKutzKDose-proportional pharmacokinetics of terbinafine and its N-demethylated metabolite in healthy volunteersBr J Dermatol1992126 Suppl 398131543677
   PubMed Web of Science ®Google Scholar
• HillSThomasRSmithSGFinlayAYAn investigation of the pharmacokinetics of topical terbinafine (Lamisil) 1% creamBr J Dermatol199212743964001419761
   PubMed Web of Science ®Google Scholar
• TanumaHDoiMOhtaYNishiyamaSKatsuokaKKanekoSUsefulness of 1% terbinafine HCl (Lamisil) cream for hyperkeratotic-type tinea pedis and its transfer into the horny layerMycoses20004311–1241743211204359
   PubMed Web of Science ®Google Scholar
• JensenJCPharmacokinetics of Lamisil in humansJ Dermatol Treat19901 Suppl 21518
   Google Scholar
• RyderNSFrankIInteraction of terbinafine with human serum and serum proteinsJ Med Vet Mycol19923064514601287164
   PubMedGoogle Scholar
• KikuchiITanumaHMorimotoKKawanaSUsefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedisMycoses200851171318076589
   PubMed Web of Science ®Google Scholar
• HumbertHCabiacMDDenouelJKirkesseliSPharmacokinetics of terbinafine and of its five main metabolites in plasma and urine, following a single oral dose in healthy subjectsBiopharm Drug Dispos19951686856948573687
   PubMed Web of Science ®Google Scholar
• Abdel-RahmanSMMarcucciKBogeTGotschallRRKearnsGLLeederJSPotent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafineDrug Metab Dispos199927777077510383919
   PubMed Web of Science ®Google Scholar
• BackDJTjiaJFAbelSMAzoles, allylamines and drug metabolismBr J Dermatol1992126 Suppl 3914181311943
   PubMed Web of Science ®Google Scholar
• SchusterIThe interaction of representative members from two classes of antimycotics--the azoles and the allylamines--with cytochromes P-450 in steroidogenic tissues and liverXenobiotica19851565295464036174
   PubMed Web of Science ®Google Scholar
• VickersAESinclairJRZollingerMHeitzFGlanzelUJohansonLMultiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactionsDrug Metab Dispos19992791029103810460803
   PubMed Web of Science ®Google Scholar
• Abdel-RahmanSMGotschallRRKauffmanRELeederJSKearnsGLInvestigation of terbinafine as a CYP2D6 inhibitor in vivoClin Pharmacol Ther199965546547210340911
   PubMed Web of Science ®Google Scholar
• CastbergIHelleJAamoTOProlonged pharmacokinetic drug interaction between terbinafine and amitriptylineTher Drug Monit200527568068216175144
   PubMed Web of Science ®Google Scholar
• HynninenVVOlkkolaKTBertilssonLKurkinenKNeuvonenPJLaineKEffect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxineClin Pharmacol Ther200883234234817687273
   PubMed Web of Science ®Google Scholar
• MadaniSBarillaDCramerJWangYPaulCEffect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizersJ Clin Pharmacol200242111211121812412819
   PubMed Web of Science ®Google Scholar
• van der KuyPHHooymansPMNortriptyline intoxication induced by terbinafineBMJ199831671294419492672
   PubMed Web of Science ®Google Scholar
• VenkatakrishnanKvon MoltkeLLGreenblattDJEffects of the antifungal agents on oxidative drug metabolism: clinical relevanceClin Pharmacokinet200038211118010709776
   PubMed Web of Science ®Google Scholar
• Lamisil Package Insert. Sandoz Pharmaceutical Corporation. 1996
   Google Scholar
• AhonenJOlkkolaKTNeuvonenPJEffect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteersBr J Clin Pharmacol19954032702728527290
   PubMed Web of Science ®Google Scholar
• BackDJStevensonPTjiaJFComparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitroBr J Clin Pharmacol19892821661702775622
   PubMed Web of Science ®Google Scholar
• SeyfferREichelbaumMJensenJCKlotzUAntipyrine metabolism is not affected by terbinafine, a new antifungal agentEur J Clin Pharmacol19893732312332612536
   PubMed Web of Science ®Google Scholar
• ShahIAWhitingPHOmarGOrmerodADBurkeMDThe effects of retinoids and terbinafine on the human hepatic microsomal metabolism of cyclosporinBr J Dermatol199312943953988217751
   PubMed Web of Science ®Google Scholar
• BreckenridgeAClinical significance of interactions with antifungal agentsBr J Dermatol1992126 Suppl 3919221311944
   PubMed Web of Science ®Google Scholar
• ZehenderHCabiacMDDenouelJFaergemannJDonatschPKutzKElimination kinetics of terbinafine from human plasma and tissue following multiple-dose administration, and comparison with 3 main metabolitesDrug Invest19948203210
   Web of Science ®Google Scholar
• OdomRPathophysiology of dermatophyte infectionsJ Am Acad Dermatol1993285 Pt 1S2S78496407
   PubMed Web of Science ®Google Scholar
• FaragATahaMHalimSOne-week therapy with oral terbinafine in cases of tinea cruris/corporisBr J Dermatol199413156846867999601
   PubMed Web of Science ®Google Scholar
• EvansEGSeamanRAJamesIGShort-duration therapy with terbinafine 1% cream in dermatophyte skin infectionsBr J Dermatol1994130183878305323
   PubMed Web of Science ®Google Scholar
• BonifazASaulAComparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporisEur J Dermatol200010210710910694308
   PubMed Web of Science ®Google Scholar
• BudimuljaUBramonoKUripKSBasukiSWidodoGRapatzGOnce daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled studyMycoses2001447–830030611714065
   PubMed Web of Science ®Google Scholar
• GreerDLJollyHWJrTreatment of tinea cruris with topical terbinafineJ Am Acad Dermatol1990234 Pt 28008042229527
   PubMed Web of Science ®Google Scholar
• LebwohlMElewskiBEisenDSavinRCEfficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea crurisCutis200167326126611270304
   PubMed Web of Science ®Google Scholar
• LedezmaELopezJCMarinPRomeroHFerraraGDe SousaLAjoene in the topical short-term treatment of tinea cruris and tinea corporis in humans. Randomized comparative study with terbinafineArzneimittelforschung199949654454710417874
   PubMed Web of Science ®Google Scholar
• MillikanLEEfficacy and tolerability of topical terbinafine in the treatment of tinea crurisJ Am Acad Dermatol1990234 Pt 27957992229526
   PubMed Web of Science ®Google Scholar
• ZaiasNBermanBCorderoCNHernandezAJacobsonCMillikanLEfficacy of a 1-week, once-daily regimen of terbinafine 1% cream in the treatment of tinea cruris and tinea corporisJ Am Acad Dermatol19932946466488408803
   PubMed Web of Science ®Google Scholar
• ColeGWStricklinGA comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporisArch Dermatol198912511153715392684023
   PubMedGoogle Scholar
• del Palacio HernandezALopez GomezSGonzalez LastraFMoreno PalancarPIglesias DiezLA comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea crurisClin Exp Dermatol19901532102162194715
   PubMed Web of Science ®Google Scholar
• VoravutinonVOral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative studyJ Med Assoc Thai19937673883938089640
   PubMedGoogle Scholar
• BudimuljaUKuswadjiKBramonoSBasukiJJudanarsoLSUntungSA double-blind, randomized, stratified controlled study of the treatment of tinea imbricata with oral terbinafine or itraconazoleBr J Dermatol1994130 Suppl 4329318186139
   PubMed Web of Science ®Google Scholar
• ShrumJPMillikanLEBatainehOSuperficial fungal infections in the tropicsDermatol Clin19941246876937805297
   PubMed Web of Science ®Google Scholar
• ElewskiBNagashima-WhalenLHoeprichPDJordanMCRonaldARSuperficial fungal infections of the skinInfectious Diseases- A treatise of infectious processes5th ed Philadelphia, PAJB Lippincott Company199410291049
   Google Scholar
• HollmenKAKinnunenTKiistalaUVaananenASaarelainenIODeCCEfficacy and tolerability of terbinafine 1% emulsion gel in patients with tinea pedisJ Eur Acad Dermatol Venereol2002161878811952304
   PubMed Web of Science ®Google Scholar
• JamesIGLoria-KanzaYJonesTCShort-duration topical treatment of tinea pedis using terbinafine emulsion gel: results of a dose-ranging clinical trialJ Dermatolog Treat2007183163817538805
   PubMed Web of Science ®Google Scholar
• KortingHCTietzHJBrautigamMMayserPRapatzGPaulCOne week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. LAS-INT-06 Study GroupMed Mycol200139433534011556763
   PubMed Web of Science ®Google Scholar
• LedezmaEMarcanoKJorqueraADe SousaLPadillaMPulgarMEfficacy of ajoene in the treatment of tinea pedis: a double-blind and comparative study with terbinafineJ Am Acad Dermatol2000435 Pt 182983211050588
   PubMed Web of Science ®Google Scholar
• LeenutaphongVNiumpraditNTangwiwatSSritaveesuwanRMuanprasatCDouble-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedisJ Med Assoc Thai199982101006101010561963
   PubMedGoogle Scholar
• PatelABrookmanSDBullenMUMarleyJEllisDHWilliamsTTopical treatment of interdigital tinea pedis: terbinafine compared with clotrimazoleAustralas J Dermatol199940419720010570555
   PubMedGoogle Scholar
• SchopfRHettlerOBrautigamMWeidingerGKabenUMayserPEfficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trialMycoses1999425–641542010536434
   PubMed Web of Science ®Google Scholar
• de ChauvinMFViguie-VallanetCKienzlerJLLarnierCNovel, single-dose, topical treatment of tinea pedis using terbinafine: results of a dose-finding clinical trialMycoses20085111618076588
   PubMed Web of Science ®Google Scholar
• OrtonneJPKortingHCViguie-VallanetCLarnierCSavalunyEEfficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete’s foot): a randomized, double-blind, placebo-controlled studyJ Eur Acad Dermatol Venereol200620101307131317062050
   PubMed Web of Science ®Google Scholar
• SavinRSuccessful treatment of chronic tinea pedis (moccasin type) with terbinafine (Lamisil)Clin Exp Dermatol19891421161192689014
   PubMed Web of Science ®Google Scholar
• SavinRCZaiasNTreatment of chronic moccasin-type tinea pedis with terbinafine: a double-blind, placebo-controlled trialJ Am Acad Dermatol1990234 Pt 28048072229528
   PubMed Web of Science ®Google Scholar
• De KeyserPDe BackerMMassartDLWestelinckKJTwo-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre studyBr J Dermatol1994130 Suppl 4322258186137
   PubMed Web of Science ®Google Scholar
• HayRJMcGregorJMWuiteJRyattKSZieglerCClaytonYMA comparison of 2 weeks of terbinafine 250 mg/day with 4 weeks of itraconazole 100 mg/day in plantar-type tinea pedisBr J Dermatol199513246046087748753
   PubMed Web of Science ®Google Scholar
• ScherRKOnychomycosis is more than a cosmetic problemBr J Dermatol1994130 Suppl 43158186135
   PubMed Web of Science ®Google Scholar
• DegreefHOnychomycosisBr J Clin Pract Suppl19907191972151117
   PubMedGoogle Scholar
• MidgleyGMooreMKCookJCPhanQGMycology of nail disordersJ Am Acad Dermatol1994313 Pt 2S68748077512
   PubMed Web of Science ®Google Scholar
• Baudraz-RosseletFRakosiTWiliPBKenzelmannRTreatment of onychomycosis with terbinafineBr J Dermatol1992126 Suppl 3940461531928
   PubMed Web of Science ®Google Scholar
• FarkasBPaulCDobozyAHunyadiJHorvathAFeketeGTerbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trialBr J Dermatol2002146225426011903236
   PubMed Web of Science ®Google Scholar
• GoodfieldMJAndrewLEvansEGShort term treatment of dermatophyte onychomycosis with terbinafineBMJ19923046835115111541392793
   PubMed Web of Science ®Google Scholar
• PollakRBillsteinSAEfficacy of terbinafine for toenail onychomycosis. A multicenter trial of various treatment durationsJ Am Podiatr Med Assoc200191312713111266494
   PubMed Web of Science ®Google Scholar
• WatsonAMarleyJEllisDWilliamsTTerbinafine in onychomycosis of the toenail: a novel treatment protocolJ Am Acad Dermatol1995335 Pt 17757797593777
   PubMed Web of Science ®Google Scholar
• ZaiasNSerranoLThe successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafineClin Exp Dermatol19891421201232532084
   PubMed Web of Science ®Google Scholar
• GuptaAKGregurek-NovakTEfficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toesDermatology2001202323523811385230
   PubMed Web of Science ®Google Scholar
• WarshawEMNelsonDCarverSMZielkeGRWebsterNLederleFAA pilot evaluation of pulse itraconazole vs terbinafine for treatment of Candida toenail onychomycosisInt J Dermatol200544978578816135154
   PubMed Web of Science ®Google Scholar
• WongCKChoYLVery short duration therapy with oral terbinafine for fingernail onychomycosisBr J Dermatol199513323293317547412
   PubMed Web of Science ®Google Scholar
• AlbaneseGDi CintioRMartiniCNicolettiAShort therapy for tinea unguium with terbinafine: four different courses of treatmentMycoses1995385–62112148531933
   PubMed Web of Science ®Google Scholar
• JenningsMBPollakRHarklessLBKianifardFTavakkolATreatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: IRON-CLAD, a large, randomized, open-label, multicenter trialJ Am Podiatr Med Assoc200696646547317114599
   PubMed Web of Science ®Google Scholar
• AvnerSNirNHenriTCombination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosisJ Dermatolog Treat2005165–632733016428154
   PubMed Web of Science ®Google Scholar
• BaranRTopical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosisBr J Dermatol2001145 Suppl 60151911777260
   PubMed Web of Science ®Google Scholar
• BaranRSigurgeirssonBde BerkerDKaufmannRLechaMFaergemannJA multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvementBr J Dermatol2007157114915717553051
   PubMed Web of Science ®Google Scholar
• GuptaAKCiclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded studyJ Drugs Dermatol20054448148516004022
   PubMedGoogle Scholar
• SigurgeirssonBElewskiBERichPAOpperCCaiBNyiradyJIntermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparisonJ Dermatolog Treat2006171384416467022
   PubMed Web of Science ®Google Scholar
• WarshawEMFettDDBloomfieldHEGrillJPNelsonDBQuinteroVPulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trialJ Am Acad Dermatol200553457858416198776
   PubMed Web of Science ®Google Scholar
• NakanoNHirumaMShirakiYChenXPorgpermdeeSIkedaSCombination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot studyJ Dermatol2006331175375817073989
   PubMed Web of Science ®Google Scholar
• JaiswalASharmaRPGargAPAn open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosisIndian J Dermatol Venereol Leprol200773639339618032857
   PubMed Web of Science ®Google Scholar
• TakahataYHirumaMShirakiYTokuhisaYSugitaTMutoMTreatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week)Mycoses2009521727618444971
   PubMed Web of Science ®Google Scholar
• FaergemannJAndersonCHersleKHradilENordinPKaamanTDouble-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosisJ Am Acad Dermatol1995325 Pt 17507537722020
   PubMed Web of Science ®Google Scholar
• HanekeETauschIBrautigamMWeidingerGWelzelDShort-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin. LAGOS III Study GroupJ Am Acad Dermatol199532172777822520
   PubMed Web of Science ®Google Scholar
• HofmannHBrautigamMWeidingerGZaunHTreatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study GroupArch Dermatol199513189199227632064
   PubMedGoogle Scholar
• ArenasRDominguez-CheritJFernandezLMOpen randomized comparison of itraconazole versus terbinafine in onychomycosisInt J Dermatol19953421381437737776
   PubMed Web of Science ®Google Scholar
• BrautigamMNoltingSSchopfREWeidingerGRandomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study GroupBMJ199531170109199227580551
   PubMed Web of Science ®Google Scholar
• DegreefHdel PalacioAMygindSGinterGPinto SoaresAZuluaga de CadenaARandomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosisActa Derm Venereol199979322122310384922
   PubMed Web of Science ®Google Scholar
• ArcaETastanHBAkarAKurumluZGurARAn open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosisJ Dermatolog Treat20021313912006131
   PubMed Web of Science ®Google Scholar
• GuptaAKGoverMDLyndeCWPulse itraconazole vs continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitusJ Eur Acad Dermatol Venereol200620101188119317062029
   PubMed Web of Science ®Google Scholar
• KejdaJItraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosisPostgrad Med1999Spec No: 12–15
   Google Scholar
• MishraMPandaPTripathySSenguptaSMishraKAn open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosisIndian J Dermatol Venereol Leprol200571426226616394436
   PubMedGoogle Scholar
• SigurgeirssonBBillsteinSRantanenTRuzickaTdi FonzoEVermeerBJL.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs Itraconazole in OnychomycosisBr J Dermatol1999141 Suppl 5651410730908
   PubMed Web of Science ®Google Scholar
• HeikkilaHStubbSLong-term results in patients with onychomycosis treated with terbinafine or itraconazoleBr J Dermatol2002146225025311903235
   PubMed Web of Science ®Google Scholar
• SigurgeirssonBOlafssonJHSteinssonJBPaulCBillsteinSEvansEGLong-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up studyArch Dermatol2002138335335711902986
   PubMedGoogle Scholar
• HavuVHeikkilaHKuokkanenKNuutinenMRantanenTSaariSA double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosisBr J Dermatol200014219710210651701
   PubMed Web of Science ®Google Scholar
• BaranRde DonckerPLateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungalsActa Derm Venereol199676182838721507
   PubMed Web of Science ®Google Scholar
• SigurgeirssonBPaulCCurranDEvansEGPrognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agentsBr J Dermatol200214761241124312452877
   PubMed Web of Science ®Google Scholar
• SommerSSheehan-DareRAGoodfieldMJEvansEGPrediction of outcome in the treatment of onychomycosisClin Exp Dermatol200328442542812823307
   PubMed Web of Science ®Google Scholar
• RobertsDTEvansEGSubungual dermatophytoma complicating dermatophyte onychomycosisBr J Dermatol199813811891909536247
   PubMed Web of Science ®Google Scholar
• O’BrienJMCommon skin problems of infancy, childhood, and adolescencePrim Care1995221991157777640
   PubMed Web of Science ®Google Scholar
• Abdel-RahmanSMNahataMCPowellDAResponse to initial griseofulvin therapy in pediatric patients with tinea capitisAnn Pharmacother19973144064109100999
   PubMed Web of Science ®Google Scholar
• BronsonDMDesaiDRBarskySFoleySMAn epidemic of infection with Trichophyton tonsurans revealed in a 20-year survey of fungal infections in ChicagoJ Am Acad Dermatol1983833223306220031
   PubMed Web of Science ®Google Scholar
• LaudeTAShahBRLynfieldYTinea capitis in BrooklynAm J Dis Child198213612104710507148756
   PubMedGoogle Scholar
• PrevostENonfluorescent tinea capitis in Charleston, SC. A diagnostic problemJAMA19792421617651767480604
   PubMed Web of Science ®Google Scholar
• FriedlanderSFAlyRKrafchikBBlumerJHonigPStewartDTerbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding studyPediatrics2002109460260711927703
   PubMed Web of Science ®Google Scholar
• HammHSchwinnABrautigamMWeidingerGShort duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. The Study GroupBr J Dermatol1999140348048210233270
   PubMed Web of Science ®Google Scholar
• HaroonTSHussainIMahmoodANagiAHAhmadIZahidMAn open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitisBr J Dermatol1992126 Suppl 3947501543673
   PubMed Web of Science ®Google Scholar
• KrafchikBPelletierJAn open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafineJ Am Acad Dermatol1999411606310411412
   PubMed Web of Science ®Google Scholar
• AsteNPauMTinea capitis caused by Microsporum canis treated with terbinafineMycoses2004479–1042843015504128
   PubMed Web of Science ®Google Scholar
• KoumantakiEKakourouTRallisERigaPGeorgallaSDoubled dose of oral terbinafine is required for Microsporum canis tinea capitisPediatr Dermatol200118433934211576412
   PubMed Web of Science ®Google Scholar
• SilmHKarelsonMTerbinafine: efficacy and tolerability in young children with tinea capitis due to Microsporum canisJ Eur Acad Dermatol Venereol200216322823012195561
   PubMed Web of Science ®Google Scholar
• AlviKHIqbalNKhanKAHaroonTSHussainIAmanSShusterSJafaryMHA randomized double-blind trial of the efficacy and tolerability of terbinafine once daily compared to griseofulvin once daily in the treatment of tinea capitisRoyal Society of Medicine Services International Congress Series19923540
   Google Scholar
• Caceres-RiosHRuedaMBallonaRBustamanteBComparison of terbinafine and griseofulvin in the treatment of tinea capitisJ Am Acad Dermatol2000421 Pt 1808410607324
   PubMed Web of Science ®Google Scholar
• FullerLCSmithCHCerioRMarsdenRAMidgleyGBeardALA randomized comparison of 4 weeks of terbinafine vs 8 weeks of griseofulvin for the treatment of tinea capitisBr J Dermatol2001144232132711251566
   PubMed Web of Science ®Google Scholar
• LipozencicJSkerlevMOrofino-CostaRZaitzVCHorvathAChouelaEA randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum speciesBr J Dermatol2002146581682312000378
   PubMed Web of Science ®Google Scholar
• UngpakornRAyutyanontTReangchainamSSupanyaSTreatment of Microsporum spp. tinea capitis with pulsed oral terbinafineClin Exp Dermatol200429330030315115516
   PubMed Web of Science ®Google Scholar
• GuptaAKAdamPDlovaNLyndeCWHofstaderSMorarNTherapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazolePediatr Dermatol200118543343811737692
   PubMed Web of Science ®Google Scholar
• ElewskiBECaceresHWDeLeonLEl ShimySHunterJAKorotkiyNTerbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trialsJ Am Acad Dermatol2008591415418378354
   PubMed Web of Science ®Google Scholar
• FaergemannJZehenderHBoukhabzaASmithSGJonesTCA double-blind comparison of levels of terbinafine and itraconazole in plasma, skin, sebum, hair and nails during and after oral medicationActa Derm Venereol199777174769059688
   PubMed Web of Science ®Google Scholar
• JungEGHaasPJBrautigamMWeidingerGSystemic treatment of skin candidosis: a randomized comparison of terbinafine and ketoconazoleMycoses1994379–103613657746297
   PubMed Web of Science ®Google Scholar
• GianniCRomanoCClinical and histological aspects of toenail onychomycosis caused by Aspergillus spp: 34 cases treated with weekly intermittent terbinafineDermatology2004209210411015316163
   PubMed Web of Science ®Google Scholar
• LiDMXiuDRLiRYSamsonRAde HoogGSWangDLAspergillus flavus myositis in a patient after liver transplantationClin Transplant200822450851118767206
   PubMed Web of Science ®Google Scholar
• Krishnan-NatesanaSChandrasekaraPHManavathuaEKRevankarSGSuccessful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafineDiagn Microbiol Infect Dis200862444344618842377
   PubMed Web of Science ®Google Scholar
• EsterrePInzanCKRamarcelERAndriantsimahavandyARatsioharanaMPecarrereJLTreatment of chromomycosis with terbinafine: preliminary results of an open pilot studyBr J Dermatol1996134Suppl 463336 discussion 408763467
   PubMed Web of Science ®Google Scholar
• XibaoZChangxingLQuanLYuqingHTreatment of chromoblastomycosis with terbinafine: a report of four casesJ Dermatolog Treat200516212112416019628
   PubMed Web of Science ®Google Scholar
• BryanCSSmithCWBergDEKarpRBCurvularia lunata endocarditis treated with terbinafine: case reportClin Infect Dis199316130328448316
   PubMed Web of Science ®Google Scholar
• ZhangJXiLLuCLiXXieTZhangHSuccessful treatment for chromoblastomycosis caused by Fonsecae monophona: a report of three cases in Guangdong, ChinaMycoses200952217618118627476
   PubMed Web of Science ®Google Scholar
• AndersonKLMitraSSaloutiRPhamTATaylorHRFungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hairCornea200423551652115220739
   PubMed Web of Science ®Google Scholar
• FordJGAgeeSGreenhawSTSuccessful medical treatment of a case of Paecilomyces lilacinus keratitisCornea20082791077107918812777
   PubMed Web of Science ®Google Scholar
• OllagueJMde ZuritaAMCaleroGParacoccidioidomycosis (South American blastomycosis) successfully treated with terbinafine: first case reportBr J Dermatol2000143118819110886159
   PubMed Web of Science ®Google Scholar
• GipLTerbinafine for black piedraLancet1993341885311648097860
   PubMed Web of Science ®Google Scholar
• WongPKChingWTKwon-ChungKJMeyerRDDisseminated Phialophora parasitica infection in humans: case report and reviewRev Infect Dis19891157707752682949
   PubMedGoogle Scholar
• CoskunBSaralYAkpolatNAtasevenACicekDSporotrichosis successfully treated with terbinafine and potassium iodide: case report and review of the literatureMycopathologia20041581535615487321
   PubMed Web of Science ®Google Scholar
• HullPRVismerHFTreatment of cutaneous sporotrichosis with terbinafineBr J Dermatol1992126 Suppl 3951551543674
   PubMed Web of Science ®Google Scholar
• FinlayAYGlobal overview of LamisilBr J Dermatol1994130 Suppl 43138186133
   PubMed Web of Science ®Google Scholar
• PollakRBillsteinSASafety of oral terbinafine for toenail onychomycosisJ Am Podiatr Med Assoc199787125655709425805
   PubMed Web of Science ®Google Scholar
• VillarsVJonesTCClinical efficacy and tolerability of terbinafine (Lamisil)--a new topical and systemic fungicidal drug for treatment of dermatomycosesClin Exp Dermatol19891421241272689015
   PubMed Web of Science ®Google Scholar
• De BackerMDe VroeyCLesaffreEScheysIDe KeyserPTwelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/dayJ Am Acad Dermatol1998385 Pt 3S57S639594939
   PubMed Web of Science ®Google Scholar
• DrakeLAShearNHArletteJPCloutierRDanbyFWElewskiBEOral terbinafine in the treatment of toenail onychomycosis: North American multicenter trialJ Am Acad Dermatol1997375 Pt 17407459366820
   PubMed Web of Science ®Google Scholar
• ChangCHYoung-XuYKurthTOravJEChanAKThe safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysisAm J Med2007120979179817765049
   PubMed Web of Science ®Google Scholar
• HallMMonkaCKruppPO’SullivanDSafety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patientsArch Dermatol199713310121312199382559
   PubMed Web of Science ®Google Scholar
• AgarwalKManasDMHudsonMTerbinafine and fulminant hepatic failureN Engl J Med1999340161292129310215503
   PubMed Web of Science ®Google Scholar
• FernandesNFGellerSAFongTLTerbinafine hepatotoxicity: case report and review of the literatureAm J Gastroenterol19989334594609517658
   PubMed Web of Science ®Google Scholar
• BrownPCAdministration FaDNDA 22–047; Lamisil^® (terbinafine hydrochloride) Oral Granules2007
   Google Scholar
• LoweGGreenCJenningsPHepatitis associated with terbinafine treatmentBMJ199330668722488443524
   PubMed Web of Science ®Google Scholar
• ParedesAHLewisJHTerbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infectionAnn Pharmacother200741588088417426078
   PubMed Web of Science ®Google Scholar
• CommitteeADRATerbinafine and blood dyscrasiasAustralian Adverse Drug Reactions Bulletin20042319
   Google Scholar
• BeltraminelliHSLerchMArnoldABircherAJHaeusermannPAcute generalized exanthematous pustulosis induced by the antifungal terbinafine: case report and review of the literatureBr J Dermatol2005152478078315840114
   PubMed Web of Science ®Google Scholar
• HivnorCMHudkinsMLBonnerBTerbinafine-induced subacute cutaneous lupus erythematosusCutis200881215615718441768
   PubMed Web of Science ®Google Scholar
• MagroCMSchaeferJTWaldmanJKnightDSeilstadKHearneDTerbinafine-induced dermatomyositis: a case report and literature review of drug-induced dermatomyositisJ Cutan Pathol2008351748118096000
   PubMed Web of Science ®Google Scholar
• CarstensJWendelboePSogaardHThestrup-PedersenKToxic epidermal necrolysis and erythema multiforme following therapy with terbinafineActa Derm Venereol19947453913927817681
   PubMed Web of Science ®Google Scholar
• GuptaAKPorgesAJHypersensitivity syndrome reaction to oral terbinafineAustralas J Dermatol19983931711729737044
   PubMedGoogle Scholar
• KovacsMJAlshammariSGuentherLBourcierMNeutropenia and pancytopenia associated with oral terbinafineJ Am Acad Dermatol1994315 Pt 18067929931
   PubMed Web of Science ®Google Scholar
• RzanyBMockenhauptMGehringWSchopfEStevens- Johnson syndrome after terbinafine therapyJ Am Acad Dermatol19943035098113475
   PubMed Web of Science ®Google Scholar
• ToddPHalpernSMunroDDOral terbinafine and erythema multiformeClin Exp Dermatol19952032472487671425
   PubMed Web of Science ®Google Scholar
• WachFStolzWHeinRLandthalerMSevere erythema anulare centrifugum-like psoriatic drug eruption induced by terbinafineArch Dermatol199513189609617632075
   PubMedGoogle Scholar
• BeutlerMHartmannKKuhnMGartmannJTaste disorders and terbinafineBMJ19933076895268343667
   PubMed Web of Science ®Google Scholar
• BongJLLuckeTWEvansCDPersistent impairment of taste resulting from terbinafineBr J Dermatol199813947477489892929
   PubMed Web of Science ®Google Scholar
• DotyRLHaxelBRObjective assessment of terbinafine-induced taste lossLaryngoscope2005115112035203716319619
   PubMed Web of Science ®Google Scholar
• DuxburyAJOliverRJPembertonMNPersistent impairment of taste associated with terbinafineBr Dent J2000188629529610800234
   PubMed Web of Science ®Google Scholar
• JuhlinLLoss of taste and terbinafineLancet1992339880714831351157
   PubMed Web of Science ®Google Scholar
• LemontHSaboMTerbinafine-associated taste disturbance with normal taste threshold scoresJ Am Podiatr Med Assoc2001911054054111734612
   PubMed Web of Science ®Google Scholar
• OttervangerJPStrickerBHLoss of taste and terbinafineLancet199234088217281355823
   PubMed Web of Science ®Google Scholar
• StrickerBHVan RiemsdijkMMSturkenboomMCOttervangerJPTaste loss to terbinafine: a case-control study of potential risk factorsBr J Clin Pharmacol19964233133188877021
   PubMed Web of Science ®Google Scholar
• GuptaAKGonderJRShearNHDilworthGRThe development of green vision in association with terbinafine therapyArch Dermatol199613278458468678591
   PubMedGoogle Scholar
• PriceTStallmanJDretlerRHAnterior uveitis in a patient with AIDS who was treated with terbinafine for oral candidiasis: a potential drug-induced reactionClin Infect Dis19972537527539314484
   PubMed Web of Science ®Google Scholar
• YulekFCagilNCakmakHBAkcayEKSimsekSKansuTBilateral anterior optic neuropathy associated with use of terbinafineClin Experiment Ophthalmol200836548848918925921
   PubMed Web of Science ®Google Scholar